Interferon gamma Protein (IFNG)

Produktnummer ABIN7849743

Recombinant Interferon gamma-Protein exprimiert in Escherichia coli (E. coli).

Kurzübersicht für Interferon gamma Protein (IFNG) (ABIN7849743)

Target: Interferon gamma (IFNG)

Protein-Typ: Recombinant

Spezies: Human

Quelle: Escherichia coli (E. coli)

Applikation: ELISA

Reinheit: >85 % by SDS-PAGE

Produktdetails

Verwendungszweck: Recombinant Human IFN gamma,IFNgamma Protein

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Tris-HCl, pH 7.4±0.2.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Ship at 4°C. Upon receipt, aliquot and store at -20°C or for long term. Avoid repeated freeze and thaw cycles.

Antigendetails

Target: Interferon gamma (IFNG)

Andere Bezeichnung: IFNgamma

Hintergrund:

Synonyms: Interferon gamma, IFNG, IFN-gamma, Immune interferon, IFN gamma, IFNr.

Description: Recombinant human IFN gamma protein.

Background: Interferon-gamma (IFN-γ), early in its history was known as immune interferon, was recognized in 1970. It dimerized soluble cytokine and is the only member of the type II class of interferons. The IFN-γ monomer consists of a core of six α-helices and an extended unfolded sequence in the C-terminal region. It is produced predominantly by natural killer (NK) and natural killer T (NKT) cells. It is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Interferon-γ 1b is used to treat chronic granulomatous disease and osteopetrosis.

Pathways: Interferon-gamma Pathway, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, ER-Nucleus Signaling, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie